Olszewski E, Kostka-Trabka E, Reroń E, Grodzińska L, Turek J, Dembińska-Kieć A, Bieroń K, Basista M, Kedzior A, Sławiński M
Kliniki Otolaryngologii AM w Krakowie.
Otolaryngol Pol. 1990;44(1):62-5.
Prostacyclin (PGI2) connects all the pharmacologic properties of drugs being used till now in sudden deafness. 30 patients with sensori-neural sudden deafness were treated by prostacyclin and placebo in the double-blind test situation. In therapeutic group of 15 patients were 87% of complete recovery, but in placebo only 6%.
前列环素（PGI2）与目前用于突发性耳聋的所有药物的药理特性相关。30例感音神经性突发性耳聋患者在双盲试验情况下接受了前列环素和安慰剂治疗。在15例患者的治疗组中，完全恢复率为87%，而安慰剂组仅为6%。
